Pharmacological response in juvenile bipolar disorder subtypes: A naturalistic retrospective examination

Psychiatry Research

Volumn 177, Issue 1-2, 2010, Pages 192-198

  Masi, Gabriele ^a   Perugi, Giulio ^b,c   Millepiedi, Stefania ^a   Mucci, Maria ^a   Pfanner, Chiara ^a   Berloffa, Stefano ^a   Pari, Cinzia ^a   Gagliano, Antonella ^d   D'Amico, Fulvio ^e   Akiskal, Hagop S ^f  

^a DEPARTMENT OF DEVELOPMENTAL NEUROSCIENCE   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c G DE LISIO INSTITUTE OF BEHAVIOURAL SCIENCES   (Italy)

^d UNIVERSITY OF MESSINA   (Italy)

^e SECOND UNIVERSITY OF NAPLES   (Italy)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adolescents; Bipolar disorder; Children; Comorbidity; Lithium; Valproic acid (VPA)

Indexed keywords

ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; LITHIUM; METHYLPHENIDATE; MOOD STABILIZER; OLANZAPINE; QUETIAPINE; RISPERIDONE; VALPROIC ACID;

ADOLESCENT; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; BIPOLAR II DISORDER; BIPOLAR MANIA; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL PRACTICE; COMORBIDITY; CONDUCT DISORDER; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; DRUG RESPONSE; FEMALE; GENERALIZED ANXIETY DISORDER; HUMAN; HYPOMANIA; JUVENILE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NATURALISTIC INQUIRY; PHOBIA; PRIORITY JOURNAL; PSYCHOSIS; RETROSPECTIVE STUDY; SCORING SYSTEM; SEPARATION ANXIETY; STEP WISE MULTIPLE REGRESSION;

ADOLESCENT; AGE FACTORS; ANTIMANIC AGENTS; BIPOLAR DISORDER; CHILD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LITHIUM CHLORIDE; MALE; PSYCHIATRIC STATUS RATING SCALES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; VALPROIC ACID;

EID: 77952094705     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2009.01.022     Document Type: Article

References (38)

1. American Psychiatric Association Diagnostic and Statistical Manual for Mental Disorders 1994, APA, Washington, DC. Fourth Edition.
2. American Academy of Child and Adolescent Psychiatry Practice parameters for the assessment and treatment of children and adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry 2007, 46:107-125.
3. Bhangoo R.K., Lowe C.H., Myers F.S., Treland J., Curran J., Towbin K.E., Leibenluft E. Medication use in children and adolescents treated in the community for bipolar disorder. Journal of Child and Adolescent Psychopharmacology 2003, 13:515-522.
4. Calabrese J.R., Shelton M.D., Rapport D.J., Youngstrom E.A., Jackson K., Bilali S., Ganocy S.J., Findling R.L. A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid cycling bipolar disorder. American Journal of Psychiatry 2005, 162:2152-2161.
5. DelBello M.P., Adler C., Strakowski S.M. Divalproex for the treatment of aggression associated with adolescent mania. Journal of Child and Adolescent Psychopharmacology 2004, 14:325-328.
6. DelBello M.P., Schwiers M., Rosenberg H., Strakowski S. Quetiapine as adjunctive treatment for adolescent mania associated with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry 2002, 41:1216-1223.
7. Duffy A., Alda M., Kutcher S., Cavazzoni P., Robertson C., Grof E., Grof P. A prospective study of the offspring of bipolar parents responsive and non responsive to lithium treatment. Journal of Clinical Psychiatry 2002, 63:1171-1178.
8. Faedda G.L., Baldessarini R.J., Glovinsky I.P., Austin N.B. Treatment-emergent mania in pediatric bipolar disorder: a retrospective case review. Journal of Affective Disorders 2004, 82:149-158.
9. Findling R.L., McNamara N.K., Gracious B.L., Youngstrom E.A., Stansbrey R.J., Reed M.D., Demeter C.A., Branicky L.A., Fisher K.E., Calabrese J.R. Combination lithium and divalproex sodium in pediatric bipolarity. Journal of the American Academy of Child and Adolescent Psychiatry 2003, 42:895-901.
10. Findling R.L., McNamara N.K., Stansbrey R., Gracious B.L., Whipkey R.E., Demeter C.A., Reed M.D., Youngstrom E.A., Calabrese J.R. Combination lithium and divalproex sodium in pediatric bipolar symptom restabilization. Journal of the American Academy of Child and Adolescent Psychiatry 2006, 45:142-148.
11. Geller B., Cooper T.B., Sun K., Zimerman B., Frazier J., Williams M., Heath J. Double-blind and placebo controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. Journal of the American Academy of Child and Adolescent Psychiatry 1998, 37:171-178.
12. Geller B., Cooper T.B., Zimerman B., Frazier Williams M., Heath J., Warner K. Lithium for prepubertal depressed children with family history predictors of future bipolarity: a double-blind, placebo-controlled study. Journal of Affective Disorders 1998, 51:165-175.
13. Guy W. ECDEU Assessment Manual for Psychopharmacology, revised. US Department of Health, Education and Welfare, Rockville, MD 1976.
14. Henry C.A., Zamvil L.S., Lam C., Rosenquist K.J., Ghaemi S.N. Long-term outcome with divalproex in children and adolescents with bipolar disorder. Journal of Child and Adolescent Psychopharmacology 2003, 13:523-529.
15. Kafantaris V., Coletti D.J., Dicker R., Padula G., Pollack S. Are childhood psychiatric histories of bipolar adolescents associated with family history, psychosis, and response to lithium treatment?. Journal of Affective Disorders 1998, 51:153-164.
16. Kafantaris V., Coletti D.J., Dicker R., Padula G., Pleak R.R., Alvir J.M. Lithium treatment of acute mania in adolescents: a placebo-controlled discontinuation study. Journal of the American Academy of Child and Adolescent Psychiatry 2004, 43:984-993.
17. Kaufman J., Birmaher B., Brent D., Rao U., Flynn C., Moreci P., Williamson D., Ryan N. Schedule for Affective Disorders and Schizophrenia for School-Age Children- Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. Journal of the American Academy of Child and Adolescent Psychiatry 1997, 36:980-988.
18. Kowatch R.A., Fristad M., Birmaher B., Wagner K.D., Findling R.L., Hellander M. Treatment guidelines for children and adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry 2005, 44:213-235. Child Psychiatric Workgroup on Bipolar Disorder.
19. Kowatch R.A., Sethuraman G., Hume J.H., Kromelis M., Weinberg W.A. Combination pharmacotherapy in children and adolescents with bipolar disorder. Biological Psychiatry 2003, 53:978-984.
20. Kowatch R.A., Suppes T., Carmody T.J., Bucci J.P., Hume J.H., Kromelis M., Emslie G.J., Weinberg W.A., Rush A.J. Effect size of lithium, divalproex, and carbamazepine in children and adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry 2000, 39:713-720.
21. Masi G., Perugi G., Toni C., Millepiedi S., Mucci M., Bertini N., Akiskal H.S. Predictors of treatment non-response in bipolar children and adolescents with manic or mixed episodes. Journal of Child and Adolescent Psychopharmacology 2004, 14:395-404.
22. Masi G., Perugi G., Millepiedi S., Mucci M., Pari C., Pfanner C., Berloffa S., Toni C. Clinical implications of DSM-IV subtyping of bipolar disorders in referred children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry 2007, 46:1299-1306.
23. Masi G., Perugi G., Millepiedi S., Toni C., Mucci M., Bertini N., Pfanner C., Berloffa S., Pari C., Akiskal K., Akiskal H.S. Clinical and research implications of panic-bipolar comorbidity in children and adolescents. Psychiatry Research 2007, 153:47-54.
24. Masi G., Toni C., Perugi G., Millepiedi S., Mucci M., Bertini N., Akiskal H.S. The clinical phenotypes of juvenile bipolar disorder: toward a validation of the episodic-chronic distinction. Biological Psychiatry 2006, 59:603-610.
25. Masi G., Toni C., Perugi G., Millepiedi S., Mucci M., Bertini N., Milantoni L., Akiskal H.S. Attention deficit hyperactivity disorder-bipolar comorbidity in children and adolescents. Bipolar Disorders 2006, 8:373-381.
26. Masi G., Perugi G., Millepiedi S., Mucci M., Toni C., Bertini N., Pfanner C., Berloffa S., Pari C. Developmental differences according to age at onset in juvenile bipolar disorder. Journal of Child and Adolescent Psychopharmacology 2006, 16:679-685.
27. Papatheodorou G., Kutcher S.P., Katic M., Szalai J.P. The efficacy and safety of divalproex sodium in the treatment of acute mania in adolescents and young adults: an open clinical trial. Journal of Clinical Psychopharmacology 1995, 15:110-116.
28. Passmore M.J., Garnham J., Duffy A., MacDougall M., Munro A., Slaney C., Teehan A., Alda M. Phenotipic spectra of bipolar disorder in responders to lithium versus lamotrigine. Bipolar Disorders 2003, 5:110-114.
29. Pavuluri M.N., Henry D.B., Devinemi B., Carbray J.A., Naylor M.W., Janicak P.G. A pharmacotherapy algorithm for stabilization and maintenance of pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry 2004, 43:859-867.
30. Pavuluri M.N., Henry D.B., Carbray J.A., Naylor N.W., Janicak P.G. Divalproex sodium for pediatric mixed mania: a 6-month prospective trial. Bipolar Disorders 2005, 7:266-273.
31. Pavuluri M.N., Henry D.B., Carbray J.A., Sampson G.A., Naylor M.W., Janicak P.G. One-year open-label trial of risperidone augmentation in lithium nonresponder youths with pre-school bipolar disorder. Journal of Child and Adolescent Psychopharmacology 2006, 16:336-350.
32. Scheffer R.E., Niskala Apps J.A. The diagnosis of preschool bipolar disorder presenting with mania: open pharmacological treatment. Journal of Affective Disorders 82 Suppl. 2004, 1:S25-S34.
33. Shaffer D., Gould M., Brasic J., Ambrosini P., Fisher P., Bird H., Aluwahlia S. Children's Global Assessment Scale (CGAS). Archives of General Psychiatry 1983, 40:1228-1231.
34. State R.C., Frye M.A., Altshuler L.L., Strober M., DeAntonio M., Hwang S., Mintz J. Chart review of the impact of attention-deficit/hyperactivity disorder comorbidity on response to lithium or divalproex sodium in adolescent mania. Journal of Clinical Psychiatry 2004, 65:1057-1063.
35. Strober M., Morrel W., Lampert C., Burroughs J. Relapse following discontinuation of lithium maintenance therapy in adolescents with bipolar I affective illness: a naturalistic study. American Journal of Psychiatry 1990, 147:457-461.
36. Strober M., DeAntonio M., Schmidt-Lackner M., Freeman R., Lampert C., Diamond J. Early childhood attention deficit hyperactivity disorder predicts poorer response to acute lithium therapy in adolescent mania. Journal of Affective Disorders 1998, 51:145-151.
37. Strober M., Schmidt-Lackner S., Freeman R., Bower S., Lampert C., DeAntonio M. Recovery and relapse in adolescents with bipolar affective illness: a five-year naturalistic, prospective follow-up. Journal of the American Academy of Child and Adolescent Psychiatry 1995, 34:724-731.
38. Wagner K.D., Weller E.B., Carlson G.A., Sachs G., Biederman J., Frazier J., Wozniak J., Tracy K., Weller R.A., Bowden C. An open trial of divalproex in children and adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry 2002, 41:1224-1230.